Atabak Mokari's Net Worth
$374 Thousand
Who is Atabak Mokari?
Atabak Mokari does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, BELLICUM PHARMACEUTICALS, INC, and IRIDEX CORP.
SEC CIK
Atabak Mokari's CIK is 0001678419
Past Insider Trading and Trends
2023 was Atabak Mokari's most active year for acquiring shares with 9 total transactions. Atabak Mokari's most active month to acquire stocks was the month of August. 2024 was Atabak Mokari's most active year for disposing of shares, totalling 3 transactions. Atabak Mokari's most active month to dispose stocks was the month of February. 2017 saw Atabak Mokari paying a total of $57,240.00 for 69,000 shares, this is the most they've acquired in one year. In 2024 Atabak Mokari cashed out on 1,231 shares for a total of $34,713.99, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $34.38
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.54% | 657 |
$34.78 | $8,656.10 | 12.52K |
Sep 3
| |||
Form 4
| +24.38% | 2.33K |
$30.74 | $28,095.33 | 11.86K |
Jun 3
| |||
Form 4
| +6.61% | 591 |
$24.06 | $890.22 | 9.54K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +12.81% | 1.02K |
$25.97 | $13,192.76 | 8.95K |
Dec 1
| |||
Form 4
| +10.75% | 796 |
$33.10 | $13,173.80 | 8.2K |
Sep 1
| |||
Form 4
| +80.42% | 3.3K |
$22.97 | $37,923.47 | 7.41K |
Jun 1
| |||
Form 4
| +158.89% | 2.52K |
$19.86 | $25,023.60 | 4.11K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
∞
| 1.59K |
$25.98 | $20,602.14 | 1.59K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BELLICUM PHARMACEUTICALS, INC (BLCM) Snapshot price: $0.2
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IRIDEX CORP (IRIX) Snapshot price: $1.8
CFO and VP Corp Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.85% | -6.01K |
$4.10 |
—
| 81.79K |
Nov 24 - Dec 11
| |||
Form 4
| +23.66% | 16.8K |
—
|
—
| 87.8K |
Jul 28
| |||
Form 4
| +9.23% | 6K |
$9.54 | $57,240.00 | 71K |
Jul 24
| |||
Form 4
|
∞
| 65K |
—
|
—
| 65K |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||